Thursday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
Data-Based IPOs: Splunk, Infoblox, Proofpoint
Debra Borchardt
It's California dreaming for these three data-based IPOs with Splunk looking the strongest.
5 Stocks Insiders Love Right Now
Roberto Pedone
Insiders at these companies have been scooping up shares of their own stock lately. (Stocks mentioned include: SEAC, COMV)
Windows Trips Up H-P's Giant 'iPad' Bet
Jonathan Blum
The HP TouchSmart 9300 PC puts iPad-like touch on your desktop. But it's still too much Microsoft, too little Apple.
Andrea Tse
Wall Street wavers after a smooth Spanish bond auction and a solid round of earnings reports is followed by a series of mixed economic indicators. Thursday's Earnings Roundup: BAC, MS, DD, TRV, DHR, VZ, EMC, NOK
Alexandra Zendrian
These companies reported earnings on Thursday before the bell. EMC Profit Climbs on Cloud, Big Data
James Rogers
Shrugging off recent tech sector unease, EMC reports solid first-quarter results. Qualcomm's Pain May Be Apple's Gain
Chris Ciaccia
Qualcomm said supply of some of its chips aren't able to keep up with demand, which likely indicates Apple continues to do exceptionally well. Molycorp Inc. Stock Upgraded (MCP)
TheStreet Wire
Molycorp (NYSE:MCP) has been upgraded by TheStreet Ratings from a sell to hold. Bank of America Beats Estimates in Noisy Quarter (Update 2)
Dan Freed
Legacy mortgage issues continue to weigh. Human Genome Rejects $2.6B Bid From GlaxoSmithKline (Update 1)
Adam Feuerstein
Human Genome Sciences rejects a $2.6 billion unsolicited offer from GlaxoSmithKline.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
